ArticleMedical & biological engineering & computing2026
A segment anything model-driven framework for multimodal active learning in breast cancer segmentation.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Medical imaging advancements have revolutionized clinical workflows; however, persistent challenges in annotation efficiency and cost continue to hinder scalable analysis. We propose a novel framework integrating the Segment Anything Model (SAM) with multimodal active learning to enhance breast cancer segmentation in Spectral Detector CT (SDCT) imaging. Our methodology combines SAM’s prompt-based segmentation capabilities with SDCT’s inherent dual-layer spectral consistency, enabling efficient annotation through expert-guided point prompts. Using a clinical dataset comprising 4996 slices from 162 breast cancer patients (32 test, 98 train, 32 validation), we demonstrate that multimodal integration of Iodine Density (IoD) and Z Effective (ZE) modalities achieves 96.75% of the performance level attained through expert manual annotations during model training, while reducing annotation costs by over 95%. Under intermediate annotation budgets, multi-click inputs and hybrid bounding box-click schemes consistently outperform single-click and box-only strategies, underscoring the value of richer spatial prompts for SAM. This SAM-driven active learning paradigm establishes a clinically viable pathway to maintain diagnostic-grade segmentation accuracy while significantly reducing resource-intensive manual annotation, thereby accelerating the translation of quantitative imaging biomarkers into routine breast cancer management.
Indexed as
Identifiers
41762429What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.